Definitive Contract HHSO100201600014C
Award Date
7/27/16
Potential Completion Date
12/31/23
Potential Value
$7.7M
Awardee
Inbios International Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Seattle, WA 98104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, specifically the Office of the Assistant Secretary for Preparedness and Response, awarded a $20,736,000 firm-fixed-price definitive contract to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the delivery of over-the-counter COVID-19 tests. The performance period is from September 20, 2023, to March 19, 2025. This contract has no set-aside designation, indicating...
This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...
This federal contract award, HHSD2002017M93163P, was made by the Centers for Disease Control and Prevention (CDC) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $198,492.00 firm fixed-price purchase order is for INBIOS EQUIPMENT, with an ultimate completion date of July 14, 2017. The contract was awarded on March 9, 2017, and was not set aside for any specific business type. Inbios International is a key partner to multiple...
The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...
This federal contract award by the Centers for Disease Control and Prevention (CDC) is for the procurement of ELISA detection kits from Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $85,485.00, is a firm fixed-price purchase order with an ultimate completion date of April 30, 2020. Inbios is a critical partner to the government, particularly during the COVID-19 pandemic, having secured numerous contracts with...
This federal contract award, valued at $5,508,014.60, was issued by the Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for Information and Communications Technology (ICT) Development on a Cost-Plus-Fixed-Fee (CPFF) basis, with a completion date of July 20, 2019. Inbios, a Subchapter S Corporation, is a manufacturer of immunodiagnostic devices for infectious diseases. This contract award...
This is a $25,655,995.03 cost-plus-fixed-fee delivery order contract awarded by the Defense Health Agency to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the development of COVID-19 antigen detection tests and optimization of serology assays as part of the FDA's Fast Track program. The contract has a period of performance through May 31, 2025. Inbios International Inc. has a history of providing critical testing products...
This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the Medical Command (MEDCOM) agency of the U.S. Department of Defense, is for ICT (Information and Communications Technology) development on a Cost-Plus-Fixed-Fee (CPFF) basis. The contract has a ceiling value of $1,724,742.02 and an ultimate completion date of September 18, 2019. The contract is not set-aside and was awarded...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $61,575 contract is for the provision of Inbios' DETECT IgM Capture ELISA Kit and accessories, which are used for infectious disease diagnostics. The award does not have a set-aside designation. Inbios has received multiple previous federal contract and grant awards from the...